Phentermine And Topiramate 00480-3296-56
- Manufacturer
- Teva Pharmaceuticals, Inc.
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIV
- Marketing Start
- May 7, 2025
- Listing Expires
- December 31, 2027
- Application
- ANDA204982
Active Ingredients
| Ingredient | Strength |
|---|---|
| Phentermine Hydrochloride | 7.5 mg/1 |
| Topiramate | 46 mg/1 |
Drug Class
Appetite Suppression [PE]Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]
Selected Package
00480-3296-56Selected30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0480-3296-56)